Skip to main content

Phathom Pharmaceuticals, Inc.

PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001783183

No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.

Holders of 5% or more of PHAT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Phathom Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of PHAT
HolderLatest formStakeChangeFirst filedLatest filingFiling
Frazier Life Sciences Public Fund, L.P.13D/A7.40%6.01M shares−1.20 ppfrom 8.60%May 5, 20238 filingsNov 2, 2026SEC
BlackRock, Inc.13G5.50%4.38M shares+0.90 ppfrom 4.60%Oct 21, 20244 filingsJul 29, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

57 Schedule 13D and 13G filings on Phathom Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on PHAT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 10, 20265:04 PM ETInvesco Ltd.13G/A0.00%30.6K shares–Below 5%Sep 30, 2026SEC
Nov 2, 20264:20 PM ETFrazier Life Sciences Public Fund, L.P.and 16 others13D/A7.40%6.01M shares−1.20 ppfrom 8.60%Oct 29, 2026SEC
Jul 29, 20263:19 PM ETBlackRock, Inc.13G5.50%4.38M shares+0.90 ppfrom 4.60%Jun 30, 2026SEC
Jul 20, 20265:52 PM ETMillennium Management LLCand 2 others13G/A4.20%3.38M shares−1.10 ppfrom 5.30%Below 5%Jun 30, 2026SEC
Mar 12, 20264:46 PM ETMillennium Management LLCand 2 others13G5.30%4.18M shares+2.60 ppfrom 2.70%Mar 6, 2026SEC
Jan 27, 20264:25 PM ETMillennium Management LLCand 3 others13G/A2.70%2.08M shares−4.40 ppfrom 7.10%Below 5%Dec 31, 2025SEC
Nov 4, 20255:24 PM ETFrazier Life Sciences Public Fund, L.P.and 16 others13D/A8.60%5.99M shares0.00 ppfrom 8.60%Nov 1, 2025SEC
Nov 3, 20254:22 PM ETMillennium Management LLCand 3 others13G/A7.10%5.08M shares+1.20 ppfrom 5.90%Sep 30, 2025SEC
Aug 28, 20254:30 PM ETCarlyle Group Inc.and 10 others13G/A4.90%3.50M shares–Below 5%Aug 28, 2025SEC
Aug 25, 20254:12 PM ETMillennium Management LLCand 3 others13G/A5.90%4.16M shares+0.60 ppfrom 5.30%Aug 19, 2025SEC
Aug 20, 20255:18 PM ETFrazier Life Sciences Public Fund, L.P.and 22 others13D/A8.60%5.99M shares−11.30 ppfrom 19.90%Aug 18, 2025SEC
Aug 13, 20254:00 PM ETMillennium Management LLCand 2 others13G5.30%3.76M sharesNewAug 11, 2025SEC
Jun 9, 202510:47 AM ETJennison Associates LLC13G/A0.00%0 shares0.00 ppfrom 0.00%Below 5%May 31, 2025SEC
Jun 6, 20251:29 PM ETPrudential Financial Inc13G/A0.00%2.63K shares−11.00 ppfrom 11.00%Below 5%May 31, 2025SEC
Jun 4, 20254:30 PM ETJennison Associates LLC13G/A0.00%0 shares–Below 5%Apr 30, 2025SEC
May 13, 20254:22 PM ETFrazier Life Sciences Public Fund, L.P.and 22 others13D/A19.90%14.4M shares–May 9, 2025SEC
Apr 24, 20252:30 PM ETBlackRock, Inc.13G/A4.60%3.23M shares–Below 5%Mar 31, 2025SEC
Nov 12, 2024BlackRock, Inc.13GOld format–––SEC
Nov 5, 20244:12 PM ETPrudential Financial Inc13G/A11.00%7.42M shares+1.70 ppfrom 9.30%Oct 31, 2024SEC
Nov 5, 20243:32 PM ETPrudential Financial Inc13G9.30%6.28M sharesNewSep 30, 2024SEC
Nov 4, 2024Jennison Associates LLC13GOld format–New–SEC
Oct 21, 2024BlackRock, Inc.13GOld format–New–SEC
Aug 22, 2024Frazier Life Sciences Public Fund, L.P.13D/AOld format–––SEC
Jun 6, 2024Frazier Life Sciences Public Fund, L.P.13D/AOld format–––SEC
Apr 10, 2024Takeda Pharmaceutical Co Ltd13D/AOld format–––SEC
Apr 1, 2024Takeda Pharmaceutical Co Ltd13D/AOld format–––SEC
Feb 12, 2024Carlyle Group Inc.13G/AOld format–––SEC
Feb 9, 2024Invesco Ltd.13G/AOld format–––SEC
Jan 26, 2024Medicxi Growth I LP13G/AOld format–––SEC
Jan 25, 2024Takeda Pharmaceutical Co Ltd13D/AOld format–––SEC
May 26, 2023Frazier Life Sciences Public Fund, L.P.13D/AOld format–––SEC
May 5, 2023Frazier Life Sciences Public Fund, L.P.13D/AOld format–––SEC
Mar 9, 2023Carlyle Group Inc.13GOld format–New–SEC
Feb 14, 2023Avidity Partners Management LP13G/AOld format–––SEC
Feb 10, 2023Flynn James E13G/AOld format–––SEC
Feb 9, 2023Janus Henderson Group PLC13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 2, 2023Invesco Ltd.13G/AOld format–––SEC
Jan 31, 2023Medicxi Growth I LP13G/AOld format–––SEC
Sep 26, 2022Frazier Life Sciences IX, L.P.13D/AOld format–––SEC
Sep 23, 2022Flynn James E13GOld format–New–SEC
Aug 11, 2022Frazier Life Sciences IX, L.P.13D/AOld format–––SEC
May 16, 2022Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2022Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2022Avidity Partners Management LP13GOld format–New–SEC
Feb 10, 2022Janus Henderson Group PLC13G/AOld format–––SEC
Feb 10, 2022Yamada Tadataka13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13GOld format–New–SEC
Feb 10, 2022Invesco Ltd.13G/AOld format–––SEC
Nov 12, 2021Takeda Pharmaceutical Co Ltd13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Phathom Pharmaceuticals, Inc. shares.

No Form 144 notices for Phathom Pharmaceuticals, Inc. are on file.